Hybrids Blurring Regulatory Lines

Derek discusses hybrid AI tools sold as business solutions that claim clinical benefits and may evade FDA oversight.

Play episode from 21:09

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!